Medications

A New Era for Diabetes and Weight Loss Drugs

For patients seeking new solutions to managing type 2 diabetes and obesity, the introduction of a class of drugs called GLP-1 receptor agonists (RA) has simultaneously inspired hope and excitement along with misuse and confusion. We developed the following Q&A to go beyond the headlines and explore how Ozempic and similar drugs work, who may benefit most from them, and why they may ultimately represent […]

Continue Reading ...

Joint Assets: An Osteoarthritis Update

Joint Assets: An Osteoarthritis Update

The aching, swollen, stiff joints associated with osteoarthritis (OA) have long been considered a “wear and tear” condition, associated with aging. It was thought that cartilage, the smooth connective tissue on the end of bones that cushion the joints, simply breaks down over a lifetime of walking, exercising and moving. New research shows that it is a disease of the entire joint that also causes […]

Continue Reading ...

Bone Up: What Is Osteoporosis?

Bone Up: What Is Osteoporosis?

Except for dedicated thespians, saying “break a leg” is most definitely not a harbinger of good luck. More than 10 million Americans are living with osteoporosis, a condition of low bone mass that results in increased risk of bone fracture, sometimes even from a minor fall or pressure from a big hug. Over 1.5 million osteoporotic fractures occur annually, and 1/3 of women and 1/5 […]

Continue Reading ...

Pandemic Inspires and Challenges Medical Innovation

Pandemic Inspires and Challenges Medical Innovation

Pandemic Sparks Promising Future for Clinical Trial Speed and Flexibility Like wartime medicine, the pandemic inspires and challenges medical innovation. The silver lining of the pandemic is the reinvigorated sense of urgency breaking down cumbersome and expensive barriers to the FDA’s phased approval process. While the research- lab-to-patient-arm trials for the highly successful COVID-19 vaccines famously moved the traditional pace to warp speed, other critical […]

Continue Reading ...

Prescription Drugs, From Pickup to Takeback

Safe Passage: Navigating Your Prescription Drugs, From Pickup to Takeback If you are not taking your prescription medications as directed (or at all), you’re far from alone: Compliance is estimated at just 50% among U.S. patients. Unfortunately, adherence is a direct impact on quality and length of life, and overall healthcare costs, accounting for up…

The post Prescription Drugs, From Pickup to Takeback appeared first on Specialdocs Consultants.

Continue Reading ...

Medical Marijuana Myths

Smoking Out the Myths: Medical Marijuana Does medical marijuana offer a solution to treating epilepsy, chronic pain, anxiety and neurogenerative diseases? Or is it an untested, potentially unsafe treatment that will eventually turn out to be more of a pipe dream? As with so many of today’s biggest questions, the truth is somewhere in between….

The post Medical Marijuana Myths appeared first on Specialdocs Consultants.

Continue Reading ...

Pain Management: The New Approach

Fewer Pills, Lower Doses, More Vigilance: The New Approach to Pain Management It’s hard to imagine a medical crisis more widely discussed, dissected and debated in the last two years than opioid abuse. As a result, clear action steps have been taken, including retooling of the 2016 guidelines for opioid-prescribing protocols – dosage recommendations, follow…

The post Pain Management: The New Approach appeared first on Specialdocs Consultants.

Continue Reading ...

The Painful New Reality of Opioid Prescriptions

Health Wise Summer 2016 Hasson FINAL 300x291

Nothing erodes the quality of life faster than pain and unfortunately more than half of American adults report they live with it on a chronic, recurring basis. That makes it easy to understand why, when seemingly safe, effective opioid drugs became widely available in the 1990s, they were quickly embraced by physicians and patients. Considered…

The post The Painful New Reality of Opioid Prescriptions appeared first on Specialdocs Consultants.

Continue Reading ...

Unlocking the Genetic Code: Spotlighting Pharmacogenomics

Hasson HW 2017 Summer FINAL 1

This is the first in a series exploring some of the most promising advances inspired by the Human Genome project. From the burgeoning field of pharmacogenomics to consumer genetic testing such as 23 and Me, the time from discovery to application is progressing rapidly. We’ll look at some of the latest thinking and its impact…

The post Unlocking the Genetic Code: Spotlighting Pharmacogenomics appeared first on Specialdocs Consultants.

Continue Reading ...
For information on our Concierge Practice, call 703-873-7425 or email us at info@novaendocenter.com